Gimv (EBR:GIMB) | WebDisclosure

Basculer en Français

10851	Companies
235675	Keywords
164625	Articles
126319	Press releases

REGULATED PRESS RELEASE

published on 11/05/2025 at 07:30, 9 months 13 days ago

Gimv bundelt krachten met Quality Guard om een toonaangevend softwareplatform voor voedselveiligheid in Europa uit te bouwen
Gimv investeert in Quality Guard voor toonaangevend voedselveiligheidsplatform in Europa. Samenwerking tussen Gimv en Quality Guard voor digitale compliance-oplossingen in foodservice en -retail

Gimv Compliance Europa Quality Guard Voedselveiligheid
REGULATED PRESS RELEASE

published on 11/05/2025 at 07:30, 9 months 13 days ago

Gimv partners with Quality Guard to establish a leading software platform for food safety compliance across Europe
Gimv partners with Quality Guard to establish a leading software platform for food safety compliance across Europe. Quality Guard offers digital tools for HACCP, food safety, and allergen management, supported by IoT-enabled hardware

Gimv SaaS Platform European Footprint Quality Guard Food Safety Compliance
BRIEF

published on 10/22/2025 at 07:35, 9 months 27 days ago

Gimv Sells Stake in ImCheck Therapeutics to Ipsen

AML Treatment ImCheck Therapeutics Ipsen Acquisition Gimv Stake Sale ICT01 Program
BRIEF

published on 10/22/2025 at 07:35, 9 months 27 days ago

Gimv cède sa participation dans Imcheck Therapeutics à Ipsen

Innovation Médicale Sciences De La Vie ImCheck Therapeutics Gimv Sortie Acquisition Ipsen
REGULATED PRESS RELEASE

published on 10/22/2025 at 07:30, 9 months 27 days ago

Gimv Life Sciences realizes successful exit with the sale of its stake in Imcheck Therapeutics to Ipsen
Gimv Life Sciences successfully exits ImCheck Therapeutics with sale to Ipsen, creating value for shareholders and advancing medical innovation in oncology

Oncology Medical Innovation Ipsen ImCheck Therapeutics Gimv Life Sciences
REGULATED PRESS RELEASE

published on 10/22/2025 at 07:30, 9 months 27 days ago

Gimv Life Sciences realizes successful exit with the sale of its stake in Imcheck Therapeutics to Ipsen
Gimv annonce la vente de sa participation dans ImCheck Therapeutics à Ipsen, marquant une étape importante pour les deux sociétés dans le secteur des sciences de la vie

Gimv Vente Sciences De La Vie Ipsen ImCheck Therapeutics
REGULATED PRESS RELEASE

published on 10/22/2025 at 07:30, 9 months 27 days ago

Gimv Life Sciences realiseert succesvolle exit met de verkoop van belang in Imcheck Therapeutics aan Ipsen.
Gimv realiseert succesvolle exit met verkoop belang Imcheck Therapeutics aan Ipsen. Strategische aanpak valoriseert investeringen in life sciences-sector

Gimv Ipsen Exit ImCheck Therapeutics Life Sciences-sector
BRIEF

published on 09/26/2025 at 07:35, 10 months 22 days ago

Spineart Secures CHF 25 Million to Boost Global Growth

Global Expansion Gimv EGS Beteiligungen Spineart CHF 25 Million
BRIEF

published on 09/26/2025 at 07:35, 10 months 22 days ago

Spineart renforce sa croissance mondiale avec un investissement de CHF 25 millions

Innovation Technologique Investissement Croissance Internationale Chirurgie Du Rachis Spineart
REGULATED PRESS RELEASE

published on 09/26/2025 at 07:30, 10 months 22 days ago

Gimv en EGS Beteiligungen versterken hun strategische steun aan Spineart met kapitaalverhoging van 25 miljoen CHF ter versnelling van wereldwijde groei
Gimv en EGSB versterken strategische steun aan Spineart met kapitaalverhoging van 25 miljoen CHF voor wereldwijde groei in wervelkolomchirurgie

Gimv Kapitaalverhoging Spineart EGSB Wervelkolomchirurgie

Accesswire

Published on 08/18/2026 at 23:10, 2 hours 21 minutes ago

Secure Blockchain Signs Agreement to Sell Delivery Trust(R) Business
Published on 08/18/2026 at 19:45, 5 hours 46 minutes ago

ECC Ventures 5 Corp. Enters Into Business Combination Agreement with Bayrock Resources for Qualifying Transaction
Published on 08/18/2026 at 18:30, 7 hours 1 minute ago

Sterling Metals Announces Approval of Arrangement by QcX Gold Shareholders
Published on 08/18/2026 at 17:40, 7 hours 51 minutes ago

Largo Physical Vanadium Announces Postponement of Annual Meeting
Published on 08/18/2026 at 17:00, 8 hours 31 minutes ago

Galaxy Ventures Inc.: TruSilver Deepens 1960s Holes to 712 Metres, Logs Sulphides Next to Past-Producing Walton Silver Mine

View all ACCESSWIRE

EQS Group

Published on 08/18/2026 at 22:00, 3 hours 30 minutes ago

Enlight Research publishes updated coverage on Eleving Group
Published on 08/18/2026 at 21:50, 3 hours 40 minutes ago

Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
Published on 08/18/2026 at 19:00, 6 hours 30 minutes ago

HIAG strengthens sustainable financing with third green bond worth CHF 100 million
Published on 08/18/2026 at 18:45, 6 hours 45 minutes ago

Information about Mr. Svetlin Todorov‘s shareholdings in Shelly Group SE
Published on 08/18/2026 at 18:10, 7 hours 20 minutes ago

Cumulus Neuroscience Announces Publication in Scientific Reports Demonstrating the NeuLogiq® Platform Is Feasible and Usable for At-Home, Multimodal Cognitive Assessment in People Living with ALS and FTD

Les Echos

Published on 08/18/2026 at 18:00, 7 hours 31 minutes ago

KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 7 hours 46 minutes ago

Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 14 hours 15 minutes ago

GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 14 hours 15 minutes ago

GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 5 hours ago

Aéroports de Paris S.A - July 2026 traffic figures

View all LES ECHOS COMFI WIRE